Bodyhealth.com, LLC
Letter data
- Company
- Bodyhealth.com, LLC
- Recipient
- Mr. David I. Minkoff | Owner | Bodyhealth.com, LLC | 745 Main St. | Dunedin | , | FL | 34698-5018 | United States | drminkoff@bodyhealth.com
- Issue date
- 2021-12-17
- Posted date
- Not available
- FDA office
- Division of Human and Animal Food Operations East IV
- Subject
- Not available
- Product
- Dietary Supplements
- CMS ID
- 610728
- Reference number
- 21-HAFE4-WL-01
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Bodyhealth.com, LLC
MARCS-CMS 610728 —
December 17, 2021
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA Electronic Mail
Reference #:
21-HAFE4-WL-01
Product:
Dietary Supplements
Recipient:
Recipient Name
Mr. David I. Minkoff
Recipient Title
Owner
Bodyhealth.com, LLC
745 Main St.
Dunedin
,
FL
34698-5018
United States
drminkoff@bodyhealth.com
Issuing Office:
Division of Human and Animal Food Operations East IV
United States
Dear Mr. Minkoff:
The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to 21-HAFE4-WL-01, dated December 09, 2020. It appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Kind regards,
/S/
Pearl Lopina
Director of Compliance Branch
OHAFO, Division IV East
Content current as of:
12/17/2021
Regulated Product(s)
Dietary Supplements